Cleared Traditional

K133865 - ASAHI GAIA FIRST, SECOND, THIRD

K133865 is an FDA 510(k) clearance for ASAHI GAIA FIRST, manufactured by Asahi Intecc Co., Ltd.. The device is a Class 2 Cardiovascular device with product code DQX cleared through the Traditional 510(k) pathway after a 89-day FDA review.

K133865 · Asahi Intecc Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2014
Decision
89d
Days
Class 2
Risk

K133865 is an FDA 510(k) clearance for the ASAHI GAIA FIRST, SECOND, THIRD. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Asahi Intecc Co., Ltd. (Baltimore, US). The FDA issued a Cleared decision on March 18, 2014 after a review of 89 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Asahi Intecc Co., Ltd. devices

FDA 510(k) Submission Details - K133865

510(k) Number K133865 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 19, 2013
Decision Date March 18, 2014
Days to Decision 89 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 125d · This submission: 89d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQX Device Classification - Class 2, Special Controls

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQX Wire, Guide, Catheter

All 622
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K133865.
INSERTION TOOL
K140673 · Boston Scientific Corp · Apr 2014
HYDROPHILIC COATED GUIDEWIRE
K133155 · Lake Region Medical · Apr 2014
MANDREL GUIDEWIRE
K140485 · Lake Region Medical · Mar 2014
VDRIVE WITH V-SONO
K133396 · Stereotaxis, Inc. · Feb 2014
MEDTRONIC CONFIDA BRECKER CURVE GUIDEWIRE
K132623 · Medtronic · Dec 2013
INQWIRE DIAGNOSTIC GUIDE WIRE
K133230 · Merit Medical Systems, Inc. · Dec 2013